ERO1A (endoplasmic reticulum oxidoreductase 1 alpha)

2007-02-01  

Identity

HGNC
LOCATION
14q22.1
LOCUSID
ALIAS
ERO1-L,ERO1-L-alpha,ERO1-alpha,ERO1L,ERO1LA,Ero1alpha
FUSION GENES

Other Information

Locus ID:

NCBI: 30001
MIM: 615435
HGNC: 13280
Ensembl: ENSG00000197930

Variants:

dbSNP: 30001
ClinVar: 30001
TCGA: ENSG00000197930
COSMIC: ERO1A

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000197930ENST00000395686Q96HE7
ENSG00000197930ENST00000554019G3V3E6
ENSG00000197930ENST00000554251G3V5B3
ENSG00000197930ENST00000556039G3V3E6
ENSG00000197930ENST00000556223G3V503
ENSG00000197930ENST00000556358G3V2H0
ENSG00000197930ENST00000629528G3V3E6

Expression (GTEx)

0
50
100
150
200

Pathways

PathwaySourceExternal ID
Vibrio cholerae infectionKEGGko05110
Vibrio cholerae infectionKEGGhsa05110
Protein processing in endoplasmic reticulumKEGGko04141
Protein processing in endoplasmic reticulumKEGGhsa04141
Metabolism of proteinsREACTOMER-HSA-392499
Peptide hormone metabolismREACTOMER-HSA-2980736
Insulin processingREACTOMER-HSA-264876
Cellular responses to stressREACTOMER-HSA-2262752
Detoxification of Reactive Oxygen SpeciesREACTOMER-HSA-3299685

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
384026232024SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA.2
384544542024Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer.1
384026232024SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA.2
384544542024Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer.1
376596212023ERO1α primes the ryanodine receptor to respond to arsenite with concentration dependent Ca(2+) release sequentially triggering two different mechanisms of ROS formation.0
377696552023Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity.6
377764732023ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway.0
376596212023ERO1α primes the ryanodine receptor to respond to arsenite with concentration dependent Ca(2+) release sequentially triggering two different mechanisms of ROS formation.0
377696552023Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity.6
377764732023ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway.0
351891092022Crosstalk between ERO1α and ryanodine receptor in arsenite-dependent mitochondrial ROS formation.6
357854922022ERO1L promotes the proliferation and metastasis of lung adenocarcinoma via the Wnt2/β-catenin signaling pathway.3
358530862022Endoplasmic reticulum oxidoreductin 1-alpha deficiency and activation of protein translation synergistically impair breast tumour resilience.6
360637272022ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA.6
351891092022Crosstalk between ERO1α and ryanodine receptor in arsenite-dependent mitochondrial ROS formation.6

Citation

Dessen P

ERO1A (endoplasmic reticulum oxidoreductase 1 alpha)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/45895/gene-fusions/haematological-explorer/welcome